Evidence map›Paper›PMID 29483929›Full record

ArticleCellular & molecular biology letters2018

Downregulation of microRNA-448 inhibits IL-1β-induced cartilage degradation in human chondrocytes via upregulation of matrilin-3.

Hao Yang, Di Wu, Hua Li, Nan Chen, Yongjun Shang

Open access · goldAbstract read
In one paragraph

Article in Cellular & molecular biology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Crosstalk Among circRNA/lncRNA, miRNA, and mRNA in Osteoarthritis.Frontiers in cell and developmental biology · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Trans-Cinnamaldehyde Inhibits IL-1BioMed research international · 2019
    Article
  16. Editorial focus: entering into the non-coding RNA era.Cellular & molecular biology letters · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hao Yang1Department of Orthopedics, First Affiliated Hospital of Kunming Medical University, Kunming, 650032 Yunnan Province People's Republic of China.
Di Wu1Department of Orthopedics, First Affiliated Hospital of Kunming Medical University, Kunming, 650032 Yunnan Province People's Republic of China.
Hua Li1Department of Orthopedics, First Affiliated Hospital of Kunming Medical University, Kunming, 650032 Yunnan Province People's Republic of China.
Nan Chen1Department of Orthopedics, First Affiliated Hospital of Kunming Medical University, Kunming, 650032 Yunnan Province People's Republic of China.
Yongjun ShangDepartment of Orthopedics, Dalian University Affiliated Xinhua Hospital, No. 156 Xinhua Street, Shahekou District, Dalian, 116021 Liaoning Province People's Republic of China.ORCID 0000-0002-8437-221X
Kunming Medical University · CNDalian University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteoarthritis is characterized by the continuous degradation of the articular cartilage. The microRNA miR-448 has been found to be broadly involved in cellular processes, including proliferation, apoptosis, invasion and EMT. While aberrant expression of miR-448 has been found in multiple cancers, its level in osteoarthritis cartilage and its role in the progression of this disease are still unknown. Here, we examined the functional roles of miR-448 and its expression in osteoarthritis tissues, including IL-1β-stimulated osteoarthritis chondrocytes.

methodsChondrocytes were isolated from human articular cartilage and stimulated with IL-1β. The expression levels of miR-448 in the cartilage and chondrocytes were both determined. After transfection with an miR-448 mimic or inhibitor, the mRNA levels of aggrecan, type II collagen and MMP-13 were determined. Luciferase reporter assay, qRT-PCR and western blot were performed to explore whether matrilin-3 was a target of miR-448. Furthermore, we co-transfected chondrocytes with miR-448 inhibitor and siRNA for matrilin-3 and then stimulated them with IL-1β to determine whether miR-448-mediated IL-1β-induced cartilage matrix degradation resulted from directly targeting matrilin-3.

resultsThe level of miR-448 was significantly higher and matrilin-3 expression was significantly lower in osteoarthritis cartilage and IL-1β-induced chondrocytes than in normal tissues and cells. Furthermore, matrilin-3 expression was reduced by miR-448 overexpression. MiR-448 downregulation significantly alleviated the IL-1β-induced downregulation of aggrecan and type II collagen expression, and upregulation of MMP-13 expression. MiR-448 overexpression had the opposite effects. Knockdown of matrilin-3 reversed the effects of the miR-448 inhibitor on the expressions of aggrecan, type II collagen and MMP-13.

conclusionThe findings showed that miR-448 contributed to the progression of osteoarthritis by directly targeting matrilin-3. This indicates that it has potential as a therapeutic target for the treatment of osteoarthritis.

Indexed as

AggrecansCartilage, ArticularCells, CulturedChondrocytesCollagen Type IIDown-RegulationGene Expression RegulationHumansInterleukin-1betaMatrilin ProteinsMatrix Metalloproteinase 13MicroRNAsOsteoarthritisRNA, MessengerUp-RegulationAggrecansCollagen Type IIInterleukin-1betaMatrilin ProteinsMatrix Metalloproteinase 13MicroRNAsMIRN448 microRNA, humanRNA, MessengerChondrocyteExtracellular matrixInterleukin-1 betaMatrilin-3MicroRNA-448Osteoarthritis

Identifiers

PMID29483929
PMCPMC5824452
OpenAlexW2789374995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.